About Us

Waarde Capital is an investment company founded by entrepreneurs for entrepreneurs. As such, we are well positioned to identify and support best companies with strong entrepreneurs.

With three active funds under management, including LBO, growth equity, and venture fund, we can invest practically on every stage of the business lifecycle, and do it globally. Waarde invests in Europe, US, Israel, Russia, and Southeast Asia.

Key Facts

 San Francisco
 geneva
 lyon
 moscow
 tel aviv
 singapore
 Amsterdam
  1. Founded by 7 entrepreneurs, who have been working together for more than  17 years
  2. Funds under management: venture capital, growth equity, and buyout fund
  3. Team experience: more than $3B invested in over 100 companies from 27 industries
  4. Global presence: Europe, Russia, Israel, US, and South-East Asia

Added Value

As entrepreneurs in nature, we are actively involved in our portfolio companies development, helping with:

Strategic planning

We help to transform a vision into game plan and practical steps.

Revenue growth

We use our extensive business network to bring new business to our portfolio companies.

Follow-on financing

We are able to provide our portfolio companies with financing for strategic M&A, CAPEX or shareholders restructuring.

Operational support

We help management teams to excel diverse operational tasks from marketing to supply chain optimization.

Turnaround and restructuring

We contribute our vast experience to help companies to get through tough times.

 

Advantages

Managing partners of Waarde Capital invest their own and other entrepreneurs’ money, and are not limited to the standard structured fund investment frames, providing portfolio companies with advantages of:

NO STRICT TIME LIMITS

We can support our portfolio companies as long as needed and adjust corporate development milestones to the economic cycle.

FLEXIBLE INVESTMENT APPROACH

Diverse capital sources allow us to provide optimal capital structure for our partners.

NO "CHINESE WALL" BETWEEN OUR FUNDS

We can finance the same company from different funds through the companies’ development . This is an efficient way to attract new co-investors and grow business faster and more easily.

Our funds

Early
stage

venture

Fund i
Vintage:
2013
UP TO
$5M in high-tech companies at startup and early growth stages.
GEO FOCUS:
Israel, Europe, Southeast Asia, USA and CIS
INVESTMENTS:
16 investments in 8 companies
CURRENT INVESTMENTS HELD:
Getgoing (USA), Cytosial (France), Xplenty (Israel), Utilight (Israel), Microchannel Systems(Russia), Inflamalps (Switzerland)

Growth capital

expansion

Fund ii
Vintage:
2015
UP TO
$15M in fast-growing companies that operate in segments with high entry barriers and have sustainable competitive advantage
REVENUE:
$3–10M
EBITDA MARGIN:
Could be negative
GEO FOCUS:
Israel, Europe, Southeast Asia and USA

Private equity/lbo

mid market

Fund iii
Vintage:
2015
UP TO
$50M in high growth mid-market companies with global expansion potential
REVENUE:
$10–100M
EBITDA MARGIN:
Positive
GEO FOCUS:
Western Europe
image

Portfolio Companies

MCS one of the eight producers of MCP (microchannel plates)
in the world
getgoing innovative technology for travel industry
Bioxis revolutionary aesthetic medical device
utilight disruptive electronics printing technology used in clean energy
xplenty makes big data available for everybody
Infamalps new molecule for treatment of inflammatory diseases
image
Russia Оptical electronic component

Production of microchannel plates (MCPs) for medical and scientific equipment in Gatchina (Leningrad Region, Russia).

MCS developed a technology that allows significant reduction of MCP’s manufacturing costs. Instead of using 3 000 sq.m. and 400 employees, MCS uses only 300 sq.m and 12 employees.

image
USA Travel management system

The Company provides the most innovative IT solutions of travel search, booking, and management.

GetGoing offers its IT platform (SaaS model) to airlines, travel management companies (TMC), corporations, online travel agencies, and other players in the travel market.

image
France Medical devices

French laboratory founded to develop new medical solutions in aesthetic medicine and tissue engineering.

Key developments of the company are dermal fillers, based on chitosan (CHITODERM) and hyaluronic acid (HYALDERM).

image
Israel Clean energy

A revolutionary technology, printing electrodes on solar panels.

The new method eliminates defects, increases efficiency of PV Cell by 4–5%, and significantly decreases production costs.

image
Israel Big data

Hadoop Cloud-based platform as a service aimed at making data analytics easy for enterprise users without special training.

Xplenty helps quickly transform structured and semi-structured data into business insights without Hadoop programming skills.

image
Switzerland Pharmaceuticals

Inflamalps is a pharmaceutical company, aiming to establish itself as a key player in the treatment of chronic inflammatory diseases by discovering and developing novel molecules with a focus on ophthalmological and dermatological diseases.

Our Team